TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest announcement is out from Airsculpt Technologies ( (AIRS) ).
On November 14, 2025, AirSculpt Technologies appointed Mike Doyle as the Non-Executive Chairman of its Board of Directors. With over 30 years of leadership experience in the multi-center healthcare sector, Doyle’s appointment is expected to guide AirSculpt in its next phase of transformation, leveraging his expertise in building successful multi-site healthcare organizations. This strategic move aims to capture new market opportunities and create value for stakeholders.
The most recent analyst rating on (AIRS) stock is a Hold with a $5.50 price target. To see the full list of analyst forecasts on Airsculpt Technologies stock, see the AIRS Stock Forecast page.
Spark’s Take on AIRS Stock
According to Spark, TipRanks’ AI Analyst, AIRS is a Neutral.
Airsculpt Technologies is currently facing significant financial and operational challenges, reflected in its low financial performance and valuation scores. The technical analysis indicates bearish momentum, further impacting the overall score. While there are strategic initiatives in place for future growth, the current financial and market conditions present substantial risks.
To see Spark’s full report on AIRS stock, click here.
More about Airsculpt Technologies
AirSculpt Technologies is a provider of premium body contouring procedures, offering a next-generation treatment that optimizes comfort and precision. The minimally invasive procedure removes fat and tightens skin, allowing for quick healing with minimal bruising, tighter skin, and precise results.
Average Trading Volume: 1,083,796
Technical Sentiment Signal: Hold
Current Market Cap: $341.5M
See more insights into AIRS stock on TipRanks’ Stock Analysis page.